Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15841004 | 0.86 | BRD4 (0.38) | — | |
| SCHEMBL15840945 | 0.84 | ALDH1A1 (0.38) | CASP3MAPTKDM4EALDH1A1HPGD | |
| SCHEMBL15840953 | 0.84 | CA1 (0.34) | MAPTKDM4EALDH1A1HPGDELANE | |
| SCHEMBL15840956 | 0.82 | PRKDC (0.42) | MAPTKDM4EALDH1A1 | |
| SCHEMBL17298924 | 0.80 | ELANE (0.35) | KDM4EALDH1A1HPGDELANE | |
| SCHEMBL15840892 | 0.79 | KDM4E (0.31) | KDM4EALDH1A1HPGD | |
| SCHEMBL15840904 | 0.77 | ALDH1A1 (0.34) | KDM4EALDH1A1HPGD | |
| SCHEMBL17268294 | 0.73 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL15829527 | 0.71 | KDM4E (0.44) | MAPTKDM4EALDH1A1HPGD | |
| SCHEMBL15840995 | 0.71 | KDM4E (0.31) | KDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2935291-B1 | IRIDIUM COMPLEXES USED IN OLIGOMERS, POLYMERS OR DENDRIMERS IN ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2019-10-16 | — | — | EP | disclosed |
| US-20150349277-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2015-12-03 | — | — | US | disclosed |
| US-20150349277-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2015-12-03 | — | — | US | disclosed |
| WO-2014094960-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2014-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150349277-A1 | METAL COMPLEXES | SOD1, AP1M1, AP3M1 | CASP3 4403/4885MAPT 1084/4885KDM4E 3816/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.